- Home
- GLDD vs RLAY Comparison
GLDD vs RLAY Comparison
Compare GLDD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLDD | RLAY |
|---|---|---|
| Founded | 1890 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2007 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GLDD | RLAY |
|---|---|---|
| Price | $16.94 | $9.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $17.00 | $14.50 |
| AVG Volume (30 Days) | ★ 2.1M | 2.0M |
| Earning Date | 05-26-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.57 | ★ 31.78 |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $702,503,000.00 | $15,355,000.00 |
| Revenue This Year | $3.79 | N/A |
| Revenue Next Year | $9.01 | $178.50 |
| P/E Ratio | $15.70 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $7.51 | $1.78 |
| 52 Week High | $16.99 | $11.43 |
Technical Indicators
Market Signals| Indicator | GLDD | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 68.29 | 59.25 |
| Support Level | $14.60 | $7.22 |
| Resistance Level | $16.99 | $11.43 |
| Average True Range (ATR) | 0.05 | 0.68 |
| MACD | -0.09 | 0.04 |
| Stochastic Oscillator | 65.38 | 43.23 |
Price Performance
Historical ComparisonAbout GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).